Life Course Adiposity and Amyotrophic Lateral Sclerosis: A Mendelian Randomization Study
The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Objective: Observational studies have indicated that life course adiposity is associated with amyotrophic lateral sclerosis (ALS). However, whether such an association reflects causality remains unclear. We aimed to determine whether life course adiposity such as birth weight (BW), childhood body mass index (BMI), adult BMI, body fat percentage (BF%), and waist‐to‐hip ratio (WHR) have causal effects on ALS. Methods: Single nucleotide polymorphisms (SNPs) significantly associated with life course adiposity were used as instrumental variables to estimate the causal effects on ALS. We used summary‐level data from a cohort of 20,806 cases and 59,804 controls in a Mendelian randomization (MR) framework. Results: Genetically predicted one standard deviation (1‐SD) increase in BF% was associated with lower risk of ALS (odds ratio [OR] = 0.67, 95% confidence interval [CI] = 0.54–0.83, p = 3.25E–04) after Bonferroni correction (p < 0.05/5). Genetically predicted 1‐SD higher childhood BMI was suggestively associated with lower risk of ALS (OR = 0.88, 95% CI = 0.78–0.99, p = 0.031). The weighted median method indicated a suggestive association between BMI and ALS (OR = 0.86, 95% CI = 0.69–0.96, p = 0.016). Neither a genetically predicted 1‐SD increase in BW (inverse variance weighted [IVW]: OR = 1.01, 95% CI = 0.87–1.17, p = 0.939) nor WHR adjusted for BMI (IVW: OR = 0.90, 95% CI = 0.76–1.05, p = 0.178) was associated with ALS. Interpretation: Our findings provide novel evidence supporting a causal role of higher adiposity, taken as a whole, on lower risk of ALS. A deeper understanding of the energy metabolism of ALS is more likely to identify feasible nutritional interventions and even novel therapeutic targets that might improve the survival of ALS patients. Ann Neurol 2020;87:434–441
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bowden, J., Davey Smith, G., & Burgess, S. (2015) · International Journal of Epidemiology · doi:10.1093/ije/dyv080 · Cited by 9,816 · cited 2×
“003) between BF% and ALS, which was mainly due to the genetic variants significantly associated with BF% (6 of 11 SNPs: rs1558902, rs4788099, rs543874, rs6567160, rs6738627, rs6755502) having similar associations with BMI but no association with ALS (see Supplementary Table 5).(22) Therefore, the 6 SNPs are valid inst…”
BackgroundBowden, J., Davey Smith, G., Haycock, P. C., & Burgess, S. (2016) · Genetic Epidemiology · doi:10.1002/gepi.21965 · Cited by 8,922
Mendelian randomization: Using genes as instruments for making causal inferences in epidemiology
Lawlor, D. A., Harbord, R. M., Sterne, J. A. C., Timpson, N., & Davey Smith, G. (2008) · Statistics in Medicine · doi:10.1002/sim.3034 · Cited by 4,618
Interpreting findings from Mendelian randomization using the MR-Egger method.
Burgess, S., & Thompson, S. G. (2017) · European Journal of Epidemiology · doi:10.1007/s10654-017-0255-x · Cited by 4,571
Burgess, S., Bowden, J., Fall, T., Ingelsson, E., & Thompson, S. G. (2017) · Epidemiology · doi:10.1097/ede.0000000000000559 · Cited by 2,017
New genetic loci link adipose and insulin biology to body fat distribution
The ADIPOGen Consortium, Shungin, D., The CARDIOGRAMplusC4D Consortium, The CKDGen Consortium, The GEFOS Consortium, The GENIE Consortium, The, G. L. G. C., The, I. C. B. P., The International Endogene Consortium, Study, T. L. C., et al. (2015) · Nature · doi:10.1038/nature14132 · Cited by 1,580 · cited 1×
“We identified IVs for WHR from a European ancestry GWAS meta-analysis of WHR involving 224,459 individuals (all from the Genetic Investigation of ANthropometric Traits [GIANT] Consortium; the GWAS data included 142,762 individuals and 81,697 individuals genotyped with the Metabochip).(20) Among the 224,459 individuals…”
MethodEvaluating the potential role of pleiotropy in Mendelian randomization studies
Hemani, G., Bowden, J., & Davey Smith, G. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy163 · Cited by 1,496 · cited 1×
“Therefore, the 6 SNPs are valid instruments.(40) Fourth, there are SNPs that were significantly associated with childhood BMI and BMI, according to the results of the study (see Supplementary Table 5).”
ResultPierce, B. L., & Burgess, S. (2013) · American Journal of Epidemiology · doi:10.1093/aje/kwt084 · Cited by 1,389 · cited 1×
“First, according to the 3 assumptions described, we used genetic variants derived from a relatively large sample size study that were strongly associated with exposure to avoid weak instrument problems,(38) but our finding may still be affected by weak instrument bias.(23,39) Second, each trait in this study was deter…”
MethodMendelian randomization: prospects, potentials, and limitations
Smith, G. D. (2004) · International Journal of Epidemiology · doi:10.1093/ije/dyh132 · Cited by 1,222
Apolipoprotein E in Alzheimer’s disease and other neurological disorders
Verghese, P. B., Castellano, J. M., & Holtzman, D. M. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70325-2 · Cited by 857 · cited 1×
“Of interest, substantial evidence indicates that APOE (rs6857-T) is a strong genetic variant for Alzheimer disease.(35) Rs6857-T (p = 2.”
BackgroundMethodological Challenges in Mendelian Randomization
VanderWeele, T. J., Tchetgen Tchetgen, E. J., Cornelis, M., & Kraft, P. (2014) · Epidemiology · doi:10.1097/ede.0000000000000081 · Cited by 555 · cited 1×
“17 Thus, we cannot exclude the possibility that adiposity, taken as a whole, mediates the entirety of the association.(41) Finally, population stratification is another potential source of bias in MR analyses.”
BackgroundFelix, J. F., Bradfield, J. P., Monnereau, C., van der Valk, R. J. P., Stergiakouli, E., Chesi, A., Gaillard, R., Feenstra, B., Thiering, E., Kreiner-Møller, E., et al. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddv472 · Cited by 343
Diabetes Mellitus, Obesity, and Diagnosis of Amyotrophic Lateral Sclerosis: A Population-Based Study
Kioumourtzoglou, M.-A., Rotem, R. S., Seals, R. M., Gredal, O., Hansen, J., & Weisskopf, M. G. (2015) · JAMA Neurology · doi:10.1001/jamaneurol.2015.0910 · Cited by 145
Causal effects of blood lipids on amyotrophic lateral sclerosis: a Mendelian randomization study
Zeng, P., & Zhou, X. (2019) · Human Molecular Genetics · doi:10.1093/hmg/ddy384 · Cited by 130 · cited 1×
“demonstrated that higher low-density lipoprotein increases the risk of ALS.(9,34) However, because it is not feasible to prevent rare diseases such as ALS, the most realistic strategy is to identify treatments and nutritional interventions that improve ALS patient survival.”
BackgroundPeter, R. S., Rosenbohm, A., Dupuis, L., Brehme, T., Kassubek, J., Rothenbacher, D., Nagel, G., & Ludolph, A. C. (2017) · European Journal of Epidemiology · doi:10.1007/s10654-017-0318-z · Cited by 113 · cited 1×
“(BW) and childhood BMI, may be a long-term modifiable factor for the onset of ALS.(3,4) Furthermore, a longitudinal”
BackgroundHigh BMI is associated with low ALS risk: A population-based study
Nakken, O., Meyer, H. E., Stigum, H., & Holmøy, T. (2019) · Neurology · doi:10.1212/wnl.0000000000007861 · Cited by 72 · cited 1×
“(BW) and childhood BMI, may be a long-term modifiable factor for the onset of ALS.(3,4) Furthermore, a longitudinal”
BackgroundThe role of pre‐morbid diabetes on developing amyotrophic lateral sclerosis
D'Ovidio, F., d'Errico, A., Carnà, P., Calvo, A., Costa, G., & Chiò, A. (2018) · European Journal of Neurology · doi:10.1111/ene.13465 · Cited by 59
Cited by
Westeneng, H.-J., van Veenhuijzen, K., van der Spek, R. A., Peters, S., Visser, A. E., van Rheenen, W., Veldink, J. H., & van den Berg, L. H. (2021) · The Lancet Neurology · doi:10.1016/s1474-4422(21)00042-9 · Cited by 58
Gut microbiome and amyotrophic lateral sclerosis: a systematic review of current evidence
Sun, J., Huang, T., Debelius, J. W., & Fang, F. (2021) · Journal of Internal Medicine · doi:10.1111/joim.13336 · Cited by 43
Self-citationLipid Metabolic Alterations in the ALS–FTD Spectrum of Disorders
Godoy-Corchuelo, J. M., Fernández-Beltrán, L. C., Ali, Z., Gil-Moreno, M. J., López-Carbonero, J. I., Guerrero-Sola, A., Larrad-Sainz, A., Matias-Guiu, J., Matias-Guiu, J. A., Cunningham, T. J., et al. (2022) · Biomedicines · doi:10.3390/biomedicines10051105 · Cited by 35
“Similarly, using mendelian randomization analysis, it has been shown that genetically determined higher adiposity and BMI suggestively decreases the risk of developing ALS [102], although these results have not been supported so far by others [98].”
MethodZhang, L., Zhuang, Z., Zhang, G., Huang, T., & Fan, D. (2022) · BMC Neurology · doi:10.1186/s12883-021-02522-z · Cited by 31
“Methods The detailed approach of selection of IVs for exposures, genome-wide association study (GWAS) summary statistics for ALS, and MR analysis were previously described [21].”
MethodSelf-citationBody mass index associates with amyotrophic lateral sclerosis survival and metabolomic profiles
Goutman, S. A., Boss, J., Iyer, G., Habra, H., Savelieff, M. G., Karnovsky, A., Mukherjee, B., & Feldman, E. L. (2023) · Muscle & Nerve · doi:10.1002/mus.27744 · Cited by 31
Metadata
- Authors
- Zhang, L., Tang, L., Huang, T., & Fan, D.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 2020-01-21
- Volume
- 87
- Issue
- 3
- Pages
- 434-441
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2998808491
- Cited by
- 40
- References
- 17
- FWCI
- 3.80
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.